Navigation Links
Royalty Pharma Statement Regarding Elan Proposal
Date:3/6/2013

The Proposal Enterprise Value therefore closely reflects the value that Royalty Pharma is ascribing to the Tysabri Royalty.

Royalty Pharma's calculation framework, analysis and assumptions, derived from publicly available information, are contained in Appendix IV.

Elan will have little or no strategic value following the Tysabri Transaction Following the completion of the Tysabri Transaction, Royalty Pharma believes that the field of likely acquirors of Elan will have narrowed sharply.

Royalty Pharma does not believe that pharmaceutical or biotech companies would be interested in acquiring Elan given that its material assets (in the context of the assets of the Elan Group, taken as a whole), following the completion of the Tysabri Transaction, will consist of cash and the Tysabri Royalty. As such, Royalty Pharma believes that the only companies that would be interested in acquiring Elan would be financial buyers. As the world's largest investor in pharmaceutical royalties, Royalty Pharma believes that it may be the only credible buyer capable of acquiring the whole of Elan.

Conclusion: the choice for Elan Shareholders is clearRoyalty Pharma's Proposal provides a clear choice for Elan Shareholders:

  • Receive what Royalty Pharma believes is the full value for Elan Stock now, in cash; or
  • Trust that Elan's acquisition strategy will succeed by remaining invested in a company with two material assets: a royalty interest in Tysabri and cash, the majority of which Elan has stated will be used for acquisitions.
  • IF ELAN SHAREHOLDERS SUPPORT THE ROYALTY PHARMA PROPOSAL, THEN THEY SHOULD ENCOURAGE THE BOARD OF ELAN TO ENGAGE WITH ROYALTY PHARMA.ELAN SHAREHOLDERS MAY NEVER GET ANOTHER OPPORTUNITY TO MAKE THIS CHOICE. Further information on Royalty PharmaRoyalty Pharma is a private entity founded in 1996 and is the investment manager to entities investing in royalty interests in marketed and late stage biopharmaceutical
    '/>"/>

    SOURCE RP Management, LLC
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

    Related biology technology :

    1. PDL BioPharma Provides Third Quarter 2012 Royalty Revenue Guidance of $85 Million
    2. Cowen Healthcare Royalty Partners Raises $1 Billion
    3. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
    4. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
    5. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
    6. AVANIR Pharmaceuticals To participate in two conferences in March
    7. Favorable Scenario for Japan Pharma Industry in Coming Years, New Report Says
    8. Hyperion Wins NDA Approval for UCD Drug Developed With Support from PharmaDirections
    9. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
    10. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
    11. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... , July 24, 2014  Spherix Incorporated (SPEX) ... fostering and monetization of intellectual property, today announced that ... period ending June 30, 2014 on Monday, August 18, ... at 10 a.m. ET on Monday, August 18, 2014 ... led by the company,s CEO, Anthony Hayes . ...
    (Date:7/23/2014)... Emirates (UAE) (PRWEB) July 23, 2014 ... recently announced that its biobanking project, Provia ... Ph.D. to its growing Advisory Board. Scott Wolf ... pleased to have Dr. Vaught onboard with Provia’s ever-expanding ... and expertise that Provia’s management team brings to this ...
    (Date:7/23/2014)... July 23, 2014 /PRNewswire-iReach/ -- Think Drinks are a ... the long term. They are the first functional focus ... energy as an alternative to the temporary fix associated ... Indiegogo on July 29, 2014, with hopes to raise ... Photo - http://photos.prnewswire.com/prnh/20140723/129697 ...
    (Date:7/23/2014)... , 23 de julio de 2014 /PRNewswire/ ... o la Compañía) ha anunciado hoy una asociación ... (ABIA o el Instituto), para el ... un dispositivo de terapia de señal bioeléctrica (el ... El Instituto, que tiene una importante experiencia ...
    Breaking Biology Technology:Spherix Schedules Shareholder Update Call 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 3Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 4truBrain Neuroscientists To Launch More Effective, Healthier Alternative To Energy Drinks On Indiegogo 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 3ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 4ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 5ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 6
    ... ... trainer Dr. Rebecca Fitzgerald, known among her medical colleagues as the "Sculptra guru" here in ... physicians at this year,s 4 day SDEF Cosmetic Dermatology Seminar held in Santa Monica, Ca. ... Los Angeles, Ca ...
    ... , SANTA ANA, Calif. , ... partnership with Prodimed, a company specializing in women,s health, located ... be distributing Prodimed,s extensive line of embryo transfer catheters, oocyte ... , , Prodimed has a ...
    ... PALO ALTO, Calif., July 21, Varian, Inc. (NasdaqGS: VARI) plans to ... 2009 after 1:00 p.m. Pacific Time (PT) on Wednesday, July 29, 2009. ... review those quarterly results is scheduled to follow at 2:00 p.m. PT ... webcast can be accessed from Varian, Inc.,s Web site at ...
    Cached Biology Technology:Looking Older Than You Are May Have Little to Do With Wrinkles 2Looking Older Than You Are May Have Little to Do With Wrinkles 3
    (Date:7/23/2014)... drought that has the entire country in its grip is ... also be responsible for the proliferation of a heat-loving amoeba ... and hot springs, which the drought has made warmer than ... of an infection caused by this parasite after swimming in ... nose of an individual and travels to the brain. Nose ...
    (Date:7/23/2014)... The Worldwide Innovative Networking in personalized cancer medicine, (the ... Center at Thomas Jefferson University will be ... member of this prestigious group in the Tri-State Area. ... of innovative personalized medicine to the patient by forging ... , "Our participation in the WIN consortium means Jefferson ...
    (Date:7/23/2014)... will play an increasingly important role in carbon and ... zones expand, according to research published this week in ... . , University of British Columbia researchers plumbed the ... to chart how microbial community metabolism changes as oxygen ... detailed picture of how SUP05 a bacterial group ...
    Breaking Biology News(10 mins):Diseases of another kind 2New partnership brings more personalized cancer treatment to Philadelphia 2Research charts the ecological impact of microbial respiration in the oxygen-starved ocean 2
    ... This release is available in French . ... of Medicine and the CHUQ Research Center have proven that ... Duchenne muscular dystrophy. The team, led by Professor Jacques P. ... published today in the online version of the scientific journal ...
    ... Program will feature new study results from the conference ... their presentation at ELCC): Making EGFR ... radiation in patients with locally advanced lung cancer: first ... lung cancer in organ transplant recipients, Hyperfractionated radiotherapy for ...
    ... PITTSBURGH, April 15 Certain genetic variations may be ... periodontitis, according to two recently published papers by researchers ... and their collaborators. Alexandre R. Vieira, D.D. S., ... professor of oral biology, and his colleagues at the ...
    Cached Biology News:Researchers prove the gene responsible for Duchenne muscular dystrophy can be repaired 22nd European Lung Cancer Conference 22nd European Lung Cancer Conference 3Pitt Dental School researchers find susceptibility for caries, gum disease in genes 2
    Goat polyclonal to SART3 ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSNADFAKLFLRK, corresponding to C terminal amino acids 951-963 of Human SART3 Entrez Gene ID: 9...
    JAB1 Immunogen: Synthetic peptide, conjugated to KLH, corresponding to residues S(201) E Y Q T I P L N K I E D F G V(216) of human JAB1. The sequence is identical in mouse and rat. Storage: -...
    Hamartin/TSC1 (1B2) Mouse mAb Ship: Hot Store: -20 C...
    Blank Calibration Particles, 3.0-3.4 mu m 5 ml...
    Biology Products: